This inventor holds 3 USPTO granted patents. Top assignees: Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts, Deutsches Krebsforschungszentrum. Active years: 2006-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2006-2012
Title: The Innovative Contributions of Sergej Kipriyanov
Introduction
Sergej Kipriyanov is a notable inventor based in Heidelberg, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of multivalent antibody constructs. With a total of three patents to his name, Kipriyanov's work has the potential to impact various medical applications.
Latest Patents
Kipriyanov's latest patents focus on multivalent antibody constructs. The first patent describes a multivalent Fantibody construct that contains at least four variable domains linked together via peptide linkers 1, 2, and 3. This invention also includes expression plasmids that code for such a Fantibody construct, along with methods for producing these constructs and their potential uses. The second patent reiterates similar details, emphasizing the innovative aspects of the multivalent antibody constructs.
Career Highlights
Throughout his career, Sergej Kipriyanov has worked with prestigious institutions, including the Deutsches Krebsforschungszentrum Stiftung Des Öffentlichen Rechts. His experience in these organizations has allowed him to advance his research and contribute to the scientific community.
Collaborations
Kipriyanov has collaborated with various professionals in his field, including Melvyn Little. These partnerships have fostered innovation and the exchange of ideas, further enhancing the impact of his work.
Conclusion
Sergej Kipriyanov's contributions to the field of biotechnology, particularly through his patents on multivalent antibody constructs, showcase his innovative spirit and dedication to advancing medical science. His work continues to inspire future research and development in this critical area.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile